Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients
Clinical trial NCT06144788 · COMPLETED
Trial details
- NCT number
- NCT06144788
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-03
- Primary completion
- 2024-12-23
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.